BIOMAT Database Logo BIOMAT Database Logo

PHARMACOLOGICALLY ACTIVE SUBSTANCES IN THEURINE OF BURNED PATIENTS. 1963

L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN

UI MeSH Term Description Entries
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D004386 Duodenum The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers. Duodenums
D004586 Electrophoresis An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current. Electrophoreses
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D014115 Toxemia A condition produced by the presence of toxins or other harmful substances in the BLOOD. Toxemias

Related Publications

L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
[Pharmacologically active substances from cactaceae].
June 1977, Deutsche medizinische Wochenschrift (1946),
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
Pharmacologically active substances in hypersensitivity reactions.
January 1967, Modern trends in immunology,
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
Pharmacologically active substances in malignant ascites fluid.
November 1970, British journal of pharmacology,
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
Isolation techniques for pharmacologically active substances (animal).
January 1969, Annual review of pharmacology,
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
Pharmacologically active and lethal substances from skin.
October 1965, Archives of environmental health,
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
[Influence of pharmacologically active substances on food safety].
September 2004, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz,
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
The release of pharmacologically active substances in parasitic infections.
January 1976, Progress in medicinal chemistry,
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
[Seasquirts (ascidians)--a new source of pharmacologically active substances].
June 1994, Pharmazie in unserer Zeit,
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
Elicitation of pharmacologically active substances in an intact medical plant.
September 2009, Journal of agricultural and food chemistry,
L G GOODWIN, and C R JONES, and W H RICHARDS, and J KOHN
Pharmacologically active substances formed in egg yolk by cobra venom.
April 1957, The Journal of physiology,
Copied contents to your clipboard!